BioSpace News Archive

Business

Chimerix Reports Third Quarter 2022 Financial Results and Provides Operational Update

Chimerix reported financial results for the third quarter ended September 30, 2022 and provided an operational update.

November 3, 2022
·
9 min read
Biotech Bay

Kura Oncology Announces Financing Transactions with Bristol Myers Squibb and Hercules Capital, Providing Access to up to $150 Million

Kura Oncology, Inc., a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, announced a $25 million equity investment from Bristol Myers Squibb and a term loan facility with access to up to $125 million from Hercules Capital, Inc.

November 3, 2022
·
6 min read
Drug Development

Atea Pharmaceuticals Presents Favorable AT-752 Phase 1 Data for Treatment of Dengue Fever at American Society of Tropical Medicine & Hygiene 2022 Annual Meeting

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, presented a poster highlighting favorable AT-752 Phase 1 clinical data for the treatment of dengue fever at the American Society of Tropical Medicine & Hygiene 2022 Annual Meeting in Seattle, Washington.

November 3, 2022
·
7 min read
Business

IRADIMED CORPORATION Announces Third Quarter 2022 Financial Results

IRADIMED CORPORATION announced its financial results for the three and nine months ended September 30, 2022.

November 3, 2022
·
15 min read
VABYSMO® (faricimab injection) receives positive CADTH recommendation for the treatment of Diabetic Macular Edema (DME) in adults

Hoffmann-La Roche Limited is pleased to announce that on October 31, 2022, the Canadian Agency for Drugs and Technologies in Health Canadian Drug Expert Committee recommended VABYSMO® for public reimbursement.

November 3, 2022
·
5 min read
BioMidwest

Merck KGaA, Darmstadt, Germany and p-Chip Corporation Collaborate to Improve Trust and Transparency in Machine-to-Machine Driven Industrial Value Chains

Merck KGaA, Darmstadt, Germany announced the conclusion of a joint development agreement to develop and implement a new solution that offers never-before-seen levels of digital trust in machine-to-machine -connected industrial value chains.

November 3, 2022
·
3 min read
BioMidwest

Bio-Techne to Present at the Credit Suisse 31st Annual Healthcare Conference

Bio-Techne Corporation announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Credit Suisse 31st Annual Healthcare Conference on Wednesday, November 9, 2022, at 8:35 a.m. PST.

November 3, 2022
·
2 min read
Biotech Beach

Five New Drug Candidates Show Promise as Ainos Pursues Licensing Partners of its Low-dose Oral Interferon Formulation

Ainos, Inc. announced that it is pursuing out-licensing opportunities for five new drug candidates for its low-dose oral interferon-alpha formulation, VELDONA®.

November 3, 2022
·
8 min read
Biotech Beach

ACELYRIN, INC. to Present at Upcoming Investor Conferences - November 03, 2022

ACELYRIN, INC. announced that its Co-founder and Chief Executive Officer Shao-Lee Lin, MD, PhD will present at the following upcoming investor conferences:

November 3, 2022
·
1 min read
CollPlant to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 17

CollPlant Biotechnologies announced that Eran Rotem, Collplant’s Deputy CEO and Chief Financial Officer, will present a company overview at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum at the Westin NY Grand Central Hotel.

November 3, 2022
·
4 min read